We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Covidien Acquires Given Imaging

By MedImaging International staff writers
Posted on 10 Mar 2014
Print article
Healthcare company Covidien, plc (Dublin, Ireland) reported that it has acquired Given Imaging, Ltd. (Yoqneam, Israel), a company that develops diagnostic products for the visualization and detection of gastrointestinal tract (GI) disorders, providing Covidien with additional range to serve an important medical specialty, the multibillion dollar global GI market.

Under terms of the merger agreement, Covidien has acquired all outstanding Given shares for USD 30 per share or an aggregate consideration of about USD 860 million, net of cash and short-term investments acquired.

“Acquiring Given Imaging significantly expands Covidien’s GI Solutions business and supports the company’s strategy to comprehensively address key global specialties and procedures,” said Bryan Hanson, group president, medical devices and United States, Covidien. “We are committed to providing clinicians with more accurate and efficient diagnostic technologies to help achieve better outcomes for patients.”

With this acquisition, Covidien now has one of the widest ranges of products for visualizing, monitoring, and detecting abnormalities in the digestive system. A key technology in the Given product range is the product PillCam, a minimally invasive, swallowed optical endoscopy technology for the small bowel, esophagus, and colon that does not require sedation of the patient.

While the company has not completed its initial purchase price allocation and the final amount could differ significantly, it estimates incremental intangible asset amortization from the transaction to be approximately USD 35 to USD 45 million on an annual basis.

Covidien is a leading global healthcare products company that creates innovative medical products. Covidien develops, manufactures, and sells a diverse range of industry-leading medical device and supply products. With 2013 revenues of USD 10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are marketed in over 150 countries.

Related Links:

Covidien 
Given Imaging


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Pre-Op Planning Solution
Sectra 3D Trauma
New
Ultrasound System
Acclarix AX9
Computed Tomography (CT) Scanner
Aquilion Serve SP

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.